Sign In
Buy SRRK
$47.30
-1.70 (-3.46%)
At Close: Jul 31, 2026
Scholar Rock Announces Pricing of Public Offering of Common Stock and Prefunded Warrants
10:33pm, Wednesday, 28'th Oct 2020
CAMBRIDGE, Mass.--(BUSINESS WIRE)--Scholar Rock Holding Corporation (Nasdaq: SRRK), a clinical-stage biopharmaceutical company focused on the treatment of serious diseases in which protein growth fact
Why Scholar Rock Stock Is Skyrocketing Today
10:46am, Tuesday, 27'th Oct 2020
Investors are fired up about the company's interim phase 2 results for an experimental spinal muscular atrophy drug.
